Pancreatic Cancer Research

ResearcherUniversity of DebrecenNo recent work listed

Shujing Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9049-2445; OpenAlex author ID A5107948530. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 2 papers · 2023: 1 paper

Papers 3

  1. NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation. Co-author DOI 10.3389/fimmu.2023.1097403↗
  2. Cuproptosis-related gene index: A predictor for pancreatic cancer prognosis, immunotherapy efficacy, and chemosensitivity. First author DOI 10.3389/fimmu.2022.978865↗
  3. A Novel Immune-Related Gene Prognostic Index (IRGPI) in Pancreatic Adenocarcinoma (PAAD) and Its Implications in the Tumor Microenvironment. Co-author DOI 10.3390/cancers14225652↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. András Hajdú · 2 shared papers, 2022 · strength 0.40
  2. Xu‐Feng Huang · 2 shared papers, 2022–2023 · strength 0.38
  3. Hajdu András · 1 shared paper, 2022 · strength 0.20
  4. Min Xu · 1 shared paper, 2023 · strength 0.18
  5. Qi Wang · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.